Why Early Trades Are Soaring For Oncternal Therapeutics (ONCT) Stock Today?
The clinical-stage biopharmaceutical company Oncternal Therapeutics, Inc. (Nasdaq: ONCT) stock is up +4.49% in the early trades today rising to $7.91 as of the writing. Although there has not been any news that could cause the ONCT stock to surge the increase in price could be attributed to the announcement of financial results unveiled by […]